Menu Back toV6-S1

14th DIA Japan Annual Meeting 2017

[V6-S1] Industry-Academia-Government Collaboration Schemes in Japan

    Session Chair(s)
      Toichi  Takenaka

      Toichi Takenaka

      • Chairman
      • Japan Health Sciences Foundation, Japan
    The Japan Agency for Medical Research and Development (AMED) was established two years ago. In order to minimize the boundaries of the industry, academia, and government in drug research, we host grant programs such as: the Department of Innovative Drug Discovery and Development (iD3) which is the first public program in Japan to deliver drug seeds from academia to clinical application, the GAPFREE program which grants public-private joint clinical research, and the Cyclic Innovation for Clinical Empowerment (CiCLE) which began in FY2017 to fund infrastructure and open innovation for medical needs based on industry-academia-government collaboration. Through these programs, we would like to discuss about the perspectives of industry-academia-government collaboration.
      Yoichi  Kurebayashi, DVM, PhD

      Drug Discovery Support Network - Recent Development & Future Perspectives

      Yoichi Kurebayashi, DVM, PhD

      • Senior Director
      • Japan Agency for Medical Research and Development (AMED), Japan
      Kazuki  Yasuda, MD

      About the Funding for Research to Expedite Effective Drug Discovery by Government, Academia and Private Partnership (GAPFREE) Program

      Kazuki Yasuda, MD

      • Department of Metabolic Disorder, Diabetes Research Center, Research Institute
      • National Center for Global Health and Medicine, Japan
      Fumihiko  Takeshita, MD, PhD

      Development of the Innovative Vaccine Technology Based on Nucleic Acid Encapsulated in Nanoparticle Supported by the Ciclic Innovation for Clinical Empowerment (CiCLE) Program

      Fumihiko Takeshita, MD, PhD

      • Senior Director (R&D) / Vice President, Vaccine Research Laboratories
      • Daiichi Sankyo Co., Ltd., Japan

Contact us

Please contact the DIA Japan office in Tokyo for further information.

Tel: +81-3-6214-0574
Fax: +81-3-3278-1313